Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest-induced amenorrhea for uterine leiomyomas
PACTR202505682460357Completed
- Sponsor
- Ain Shams University
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of dienogest in Fibromyoma (LM), sponsored by Ain Shams University. Primary endpoint: Leiomyoma volume. Started Sep 2023; status: completed.
02
Drugs
dienogest
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on PACTR202505682460357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202505682460357.